Pluri Inc. Basic Shares Outstanding (Weighted Average)
Pluri Inc. (PLUR) reported Basic Shares Outstanding (Weighted Average) of 9.74 million shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-09-10
- Pluri Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 10.68M shares, a 37.37% increase year-over-year.
- Pluri Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 10.05M shares, a 53.19% increase year-over-year.
- Pluri Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 9.26M shares, a 66.77% increase year-over-year.
- Pluri Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 9.00M shares, a 64.78% increase year-over-year.
- Pluri Inc. weighted average number of shares outstanding, basic for fiscal 2026 was 9.74M shares, a 53.76% increase from fiscal 2025.
- Pluri Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 6.34M shares, a 20.93% increase from fiscal 2024.
- Pluri Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 5.24M shares, a 14.38% increase from fiscal 2023.
- Pluri Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 4.58M shares, a 85.77% decline from fiscal 2022.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 10.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | 10.37M shares derived: average of 2 quarters · filed 2026-09-10 | 10.00M shares derived: average of 3 quarters · filed 2026-09-10 | 9.74M shares 10-K · filed 2026-09-10 | ||||
| 2026-03-31 | 10.05M shares 10-Q · filed 2026-05-14 | 9.66M shares derived: average of 2 quarters · filed 2026-05-14 | 9.43M shares 10-Q · filed 2026-05-14 | 9.02M shares derived: average of 4 quarters · filed 2026-09-10 | ||||
| 2025-12-31 | 9.26M shares 10-Q · filed 2026-02-12 | 9.13M shares 10-Q · filed 2026-02-12 | 8.68M shares derived: average of 3 quarters · filed 2026-09-10 | 8.15M shares derived: average of 4 quarters · filed 2026-09-10 | ||||
| 2025-09-30 | 9.00M shares 10-Q · filed 2025-11-12 | 8.39M shares derived: average of 2 quarters · filed 2026-09-10 | 7.78M shares derived: average of 3 quarters · filed 2026-09-10 | 7.22M shares derived: average of 4 quarters · filed 2026-09-10 | ||||
| 2025-06-30 | 7.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | 7.17M shares derived: average of 2 quarters · filed 2026-09-10 | 6.63M shares derived: average of 3 quarters · filed 2026-09-10 | 6.34M shares 10-K · filed 2026-09-10 | ||||
| 2025-03-31 | 6.56M shares 10-Q · filed 2026-05-14 | 6.06M shares derived: average of 2 quarters · filed 2026-05-14 | 5.86M shares 10-Q · filed 2026-05-14 | 5.74M shares derived: average of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | 5.55M shares 10-Q · filed 2026-02-12 | 5.51M shares 10-Q · filed 2026-02-12 | 5.46M shares derived: average of 3 quarters · filed 2026-02-12 | 5.40M shares derived: average of 4 quarters · filed 2026-02-12 | ||||
| 2024-09-30 | 5.46M shares 10-Q · filed 2025-11-12 | 5.42M shares derived: average of 2 quarters · filed 2025-11-12 | 5.35M shares derived: average of 3 quarters · filed 2025-11-12 | 5.31M shares derived: average of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | 5.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17 | 5.30M shares derived: average of 2 quarters · filed 2025-09-17 | 5.26M shares derived: average of 3 quarters · filed 2025-09-17 | 5.24M shares 10-K · filed 2025-09-17 | ||||
| 2024-03-31 | 5.22M shares 10-Q · filed 2025-05-13 | 5.21M shares derived: average of 2 quarters · filed 2025-05-13 | 5.19M shares 10-Q · filed 2025-05-13 | 5.17M shares derived: average of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | 5.19M shares 10-Q · filed 2025-02-11 | 41.53M shares 10-Q · filed 2024-02-12 | 5.18M shares 10-Q · filed 2025-02-11 | 41.43M shares 10-Q · filed 2024-02-12 | 5.16M shares derived: average of 3 quarters · filed 2025-02-11 | 5.12M shares derived: average of 4 quarters · filed 2025-02-11 | ||
| 2023-09-30 | 5.17M shares 10-Q · filed 2024-11-12 | 41.33M shares 10-Q · filed 2023-11-13 | 5.14M shares derived: average of 2 quarters · filed 2024-11-12 | 5.09M shares derived: average of 3 quarters · filed 2024-11-12 | 12.12M shares derived: average of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | 5.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | 5.06M shares derived: average of 2 quarters · filed 2024-09-18 | 14.44M shares derived: average of 3 quarters · filed 2024-09-18 | 4.58M shares 10-K · filed 2024-09-18 | 36.65M shares 10-K · filed 2023-09-12 | |||
| 2023-03-31 | 4.99M shares 10-Q · filed 2024-05-09 | 39.95M shares 10-Q · filed 2023-05-09 | 19.09M shares derived: average of 2 quarters · filed 2024-05-09 | 4.40M shares 10-Q · filed 2024-05-09 | 35.22M shares 10-Q · filed 2023-05-09 | 25.78M shares derived: average of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | 33.19M shares 10-Q · filed 2024-02-12 | 32.88M shares 10-Q · filed 2024-02-12 | 32.71M shares derived: average of 3 quarters · filed 2024-02-12 | 32.60M shares derived: average of 4 quarters · filed 2024-02-12 | ||||
| 2022-09-30 | 32.56M shares 10-Q · filed 2023-11-13 | 32.47M shares derived: average of 2 quarters · filed 2023-11-13 | 32.40M shares derived: average of 3 quarters · filed 2023-11-13 | 32.33M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | 32.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | 32.32M shares derived: average of 2 quarters · filed 2023-09-12 | 32.26M shares derived: average of 3 quarters · filed 2023-09-12 | 32.19M shares 10-K · filed 2023-09-12 | ||||
| 2022-03-31 | 32.26M shares 10-Q · filed 2023-05-09 | 32.20M shares derived: average of 2 quarters · filed 2023-05-09 | 32.13M shares 10-Q · filed 2023-05-09 | |||||
| 2021-12-31 | 32.14M shares 10-Q · filed 2023-02-13 | 32.07M shares 10-Q · filed 2023-02-13 | ||||||
| 2021-09-30 | 32.00M shares 10-Q · filed 2022-11-10 | |||||||
| 2021-06-30 | 28.11M shares 10-K · filed 2022-09-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |